메뉴 건너뛰기




Volumn 13, Issue 4, 2011, Pages 460-465

Clinical trials update from the American Heart Association Meeting 2010: EMPHASIS-HF, RAFT, TIM-HF, Tele-HF, ASCEND-HF, ROCKET-AF, and PROTECT

Author keywords

Heart failure; Randomized controlled trials

Indexed keywords

ALDOSTERONE ANTAGONIST; ALDOSTERONE RECEPTOR ANTAGONIST; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CANRENONE; CORTICOSTEROID ANTAGONIST; DABIGATRAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPLERENONE; NESIRITIDE; NITRATE; OPIATE; PLACEBO; RIVAROXABAN; SPIRONOLACTONE; UNCLASSIFIED DRUG; VASODILATOR AGENT; WARFARIN;

EID: 79953149155     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfr015     Document Type: Article
Times cited : (32)

References (27)
  • 1
    • 0033517302 scopus 로고    scopus 로고
    • The effect of spironolactone on morbidity and mortality in patients with severe heart failure
    • DOI 10.1056/NEJM199909023411001
    • Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomised Aldactone Evaluation Study Investigators. N Eng J Med 1999;341:709-717. (Pubitemid 29407370)
    • (1999) New England Journal of Medicine , vol.341 , Issue.10 , pp. 709-717
    • Pitt, B.1    Zannad, F.2    Remme, W.J.3    Cody, R.4    Castaigne, A.5    Perez, A.6    Palensky, J.7    Wittes, J.8
  • 2
    • 0037417252 scopus 로고    scopus 로고
    • Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
    • DOI 10.1056/NEJMoa030207
    • Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M, for the Eplerenone post-acute myocardial infarction heart failure efficacy and survival study investigators. Eplerenone, a selective aldoster-one blocker in patients with left ventricular dysfunction after myocardial infarction. N Eng J Med 2003;348:1309-21. (Pubitemid 36384098)
    • (2003) New England Journal of Medicine , vol.348 , Issue.14 , pp. 1309-1321
    • Pitt, B.1    Remme, W.2    Zannad, F.3    Neaton, J.4    Martinez, F.5    Roniker, B.6    Bittman, R.7    Hurley, S.8    Kleiman, J.9    Gatlin, M.10
  • 3
    • 53549085406 scopus 로고    scopus 로고
    • ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008
    • The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)
    • Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008;10:933-989.
    • (2008) Eur J Heart Fail , vol.10 , pp. 933-989
    • Dickstein, K.1    Cohen-Solal, A.2    Filippatos, G.3    McMurray, J.J.4    Ponikowski, P.5    Poole-Wilson, P.A.6    Stromberg, A.7    Van Veldhuisen, D.J.8    Atar, D.9    Hoes, A.W.10    Keren, A.11    Mebazaa, A.12    Nieminen, M.13    Priori, S.G.14    Swedberg, K.15
  • 5
    • 77954739690 scopus 로고    scopus 로고
    • Randomized double-blind multicentre placebo-controlled study evaluating the effect of aldosterone antagonism with eplerenone on ventricular remodelling in patients with mild-to-moderate heart failure and left ventricular systolic dysfunction
    • Udelson JE, Feldman AM, Greenberg B, Pitt B, Mukherjee R, Solomon HA, Konstam MA. Randomized double-blind multicentre placebo-controlled study evaluating the effect of aldosterone antagonism with eplerenone on ventricular remodelling in patients with mild-to-moderate heart failure and left ventricular systolic dysfunction. Circ Heart Fail 2010;3:347-353.
    • (2010) Circ Heart Fail , vol.3 , pp. 347-353
    • Udelson, J.E.1    Feldman, A.M.2    Greenberg, B.3    Pitt, B.4    Mukherjee, R.5    Solomon, H.A.6    Konstam, M.A.7
  • 8
    • 78649370678 scopus 로고    scopus 로고
    • Effect of eplerenone versus spironolactone on cortisol and hemoglobin A1(c) levels in patients with chronic heart failure
    • Yamaji M, Tsutamoto T, Kawahara C, Nishiyama K, Yamamoto T, Fuji M, Horie M. Effect of eplerenone versus spironolactone on cortisol and hemoglobin A1(c) levels in patients with chronic heart failure. Am Heart J 2010;160:915-921.
    • (2010) Am Heart J , vol.160 , pp. 915-921
    • Yamaji, M.1    Tsutamoto, T.2    Kawahara, C.3    Nishiyama, K.4    Yamamoto, T.5    Fuji, M.6    Horie, M.7
  • 9
    • 72949104923 scopus 로고    scopus 로고
    • Implementation of device therapy (cardiac resynchronisation therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: Changes from 2004 to 2008
    • van Veldhuisen DJ, Maas AH, Priori SG, Stolt P, van Gelder IC, Dickstein K, Swedberg K. Implementation of device therapy (cardiac resynchronisation therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008. Eur J Heart Fail 2009;11: 1143-1151.
    • (2009) Eur J Heart Fail , vol.11 , pp. 1143-1151
    • Van Veldhuisen, D.J.1    Maas, A.H.2    Priori, S.G.3    Stolt, P.4    Van Gelder, I.C.5    Dickstein, K.6    Swedberg, K.7
  • 12
    • 30744464127 scopus 로고    scopus 로고
    • Cardiac resynchronisation for patients with heart failure due to left ventricular systolic dysfunction - a systematic review and meta-analysis
    • DOI 10.1016/j.ejheart.2005.11.014, PII S1388984205003399
    • Freemantle N, Tharmanathan P, Calvert MJ, Abraham WT, Ghosh J, Cleland JGF. Cardiac resynchronisation for patients with heart failure due to left ventricular systolic dysfunction-a systematic review and meta-analysis. Eur J Heart Fail 2006;8:433-440. (Pubitemid 43832169)
    • (2006) European Journal of Heart Failure , vol.8 , Issue.4 , pp. 433-440
    • Freemantle, N.1    Tharmanathan, P.2    Calvert, M.J.3    Abraham, W.T.4    Ghosh, J.5    Cleland, J.G.F.6
  • 13
    • 56349114416 scopus 로고    scopus 로고
    • Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms
    • REVERSE Study Group
    • Linde C, Abraham WT, Gold MR, St John Sutton M, Ghio S, Daubert C, REVERSE Study Group. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol 2008;52: 1834-1843.
    • (2008) J Am Coll Cardiol , vol.52 , pp. 1834-1843
    • Linde, C.1    Abraham, W.T.2    Gold, M.R.3    St John Sutton, M.4    Ghio, S.5    Daubert, C.6
  • 14
    • 33748058451 scopus 로고    scopus 로고
    • Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]
    • DOI 10.1093/eurheartj/ehl099
    • Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L. Longer term effects of cardiac resynchronization therapy on mortality in heart failure [the cardiac resynchronization-heart failure (CARE-HF) trial extension phase]. Eur Heart J 2006;16:1928-1932. (Pubitemid 44297365)
    • (2006) European Heart Journal , vol.27 , Issue.16 , pp. 1928-1932
    • Cleland, J.G.F.1    Daubert, J.-C.2    Erdmann, E.3    Freemantle, N.4    Gras, D.5    Kappenberger, L.6    Tavazzi, L.7
  • 15
    • 39749194940 scopus 로고    scopus 로고
    • Long-term effect of cardiac resynchronisation in patients reporting mild symptoms of heart failure: A report from the CARE-HF study
    • DOI 10.1136/hrt.2007.128991
    • Cleland JGF, Freemantle N, Daubert JC, Toff WD, Leisch F, Tavazzi L. Long-term effect of cardiac resynchronisation in patients reporting mild symptoms of heart failure: a report from the CARE-HF study. Heart 2008;94:278-283. (Pubitemid 351303415)
    • (2008) Heart , vol.94 , Issue.3 , pp. 278-283
    • Cleland, J.G.F.1    Freemantle, N.2    Daubert, J.-C.3    Toff, W.D.4    Leisch, F.5    Tavazzi, L.6
  • 17
    • 79953156220 scopus 로고    scopus 로고
    • Which components of heart failure programmes are effective? A meta-analysis of the outcomes of structured telephone support or telemonitoring as the primary component of chronic heart failure management in 9,560 patients (Abridged Cochrane Review)
    • in press doi:10.1093/eurjhf/hfr039
    • Inglis SC, Clark RA, McAlister FA, Stewart S, Cleland JGF. Which components of heart failure programmes are effective? A meta-analysis of the outcomes of structured telephone support or telemonitoring as the primary component of chronic heart failure management in 9,560 patients (Abridged Cochrane Review). Eur J Heart Fail 2011 (in press); doi:10.1093/eurjhf/hfr039.
    • (2011) Eur J Heart Fail
    • Inglis, S.C.1    Clark, R.A.2    McAlister, F.A.3    Stewart, S.4    Jgf, C.5
  • 20
    • 0037142946 scopus 로고    scopus 로고
    • Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): A randomised double-blind trial
    • DOI 10.1016/S0140-6736(02)09455-2
    • Follath F, Cleland JGF, Just H, Papp JG, Scholz H, Peuhkurinen K, Harjola VP, Mitrovic V, Abdalla M, Sandell EP, Lehtonen L. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 2002;360:196-202. (Pubitemid 34804646)
    • (2002) Lancet , vol.360 , Issue.9328 , pp. 196-202
    • Follath, F.1    Cleland, J.G.F.2    Just, H.3    Papp, J.G.Y.4    Scholz, H.5    Peuhkurinen, K.6    Harjola, V.P.7    Mitrovic, V.8    Abdalla, M.9    Sandell, E.-P.10    Lehtonen, L.11
  • 23
    • 72949111668 scopus 로고    scopus 로고
    • Clinical trials update from the European Society of Cardiology Meeting 2009: AAA, RELY, PROTECT, ACTIVE-I, European CRT survey, German pre-SCD II registry, and MADIT-CRT
    • Cleland JGF, Coletta AP, Yassin A, Buga L, Torabi A, Clark AL. Clinical trials update from the European Society of Cardiology Meeting 2009: AAA, RELY, PROTECT, ACTIVE-I, European CRT survey, German pre-SCD II registry, and MADIT-CRT. Eur J Heart Fail 2009;11:1214-1219.
    • (2009) Eur J Heart Fail , vol.11 , pp. 1214-1219
    • Jgf, C.1    Coletta, A.P.2    Yassin, A.3    Buga, L.4    Torabi, A.5    Clark, A.L.6
  • 25
    • 67749098636 scopus 로고    scopus 로고
    • Clinical trials update from the American College of Cardiology 2009: ADMIRE-HF, PRIMA, STICH, REVERSE, IRIS, partial ventricular support, FIX-HF-5, vagal stimulation, REVIVAL-3, pre-RELAX-AHF, ACTIVE-A, HF-ACTION, JUPITER, AURORA and OMEGA
    • Cleland JGF, Coletta AP, Clark AL, Cullington D. Clinical trials update from the American College of Cardiology 2009: ADMIRE-HF, PRIMA, STICH, REVERSE, IRIS, partial ventricular support, FIX-HF-5, vagal stimulation, REVIVAL-3, pre-RELAX-AHF, ACTIVE-A, HF-ACTION, JUPITER, AURORA and OMEGA. Eur J Heart Fail 2009;11:622-630.
    • (2009) Eur J Heart Fail , vol.11 , pp. 622-630
    • Jgf, C.1    Coletta, A.P.2    Clark, A.L.3    Cullington, D.4
  • 27
    • 68849114272 scopus 로고    scopus 로고
    • Biomarker guided therapy in chronic heart failure: A meta-analysis of randomized controlled trials
    • Felker GM, Hasselblad V, Hernandez AF, O'Connor CM. Biomarker guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials. Am Heart J 2009;158:422-430.
    • (2009) Am Heart J , vol.158 , pp. 422-430
    • Felker, G.M.1    Hasselblad, V.2    Hernandez, A.F.3    O'Connor, C.M.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.